Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Julphar
Fuji
AstraZeneca
Johnson and Johnson
Dow
Baxter
Chinese Patent Office

Generated: May 23, 2018

DrugPatentWatch Database Preview

Fibrinogen, i-125 - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for fibrinogen, i-125 and what is the scope of fibrinogen, i-125 patent protection?

Fibrinogen, i-125
is the generic ingredient in two branded drugs marketed by Ge Healthcare and Abbott, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for fibrinogen, i-125
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Clinical Trials: 164
Formulation / Manufacturing:see details
DailyMed Link:fibrinogen, i-125 at DailyMed

US Patents and Regulatory Information for fibrinogen, i-125

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott RADIONUCLIDE-LABELED (125 I) FIBRINOGEN (HUMAN) SENSOR fibrinogen, i-125 INJECTABLE;INJECTION 017787-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ge Healthcare IBRIN fibrinogen, i-125 INJECTABLE;INJECTION 017879-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Baxter
Medtronic
Chubb
McKinsey
Moodys
Merck
Deloitte
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.